Evidence map›Paper›PMID 35075615›Full record

ArticleReproductive sciences (Thousand Oaks, Calif.)2022

Impairment of Decidualization of Endometrial Stromal Cells by hsa-miR-375 Through NOX4 Targeting.

Seong-Lan Yu, Da-Un Jeong, Yujin Kang, Tae-Hyun Kim, Sung Ki Lee, Ae-Ra Han, Jaeku Kang, Seok-Rae Park

Open access · hybridAbstract read
In one paragraph

Article in Reproductive sciences (Thousand Oaks, Calif.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Seong-Lan YuPriority Research Center, Myunggok Medical Research Institute, College of Medicine, Konyang University, Daejeon, Republic of Korea.
Da-Un JeongPriority Research Center, Myunggok Medical Research Institute, College of Medicine, Konyang University, Daejeon, Republic of Korea.
Yujin KangPriority Research Center, Myunggok Medical Research Institute, College of Medicine, Konyang University, Daejeon, Republic of Korea.
Tae-Hyun KimPriority Research Center, Myunggok Medical Research Institute, College of Medicine, Konyang University, Daejeon, Republic of Korea.
Sung Ki LeePriority Research Center, Myunggok Medical Research Institute, College of Medicine, Konyang University, Daejeon, Republic of Korea.
Ae-Ra HanI-Dream Clinic, Department of Obstetrics and Gynecology, Mizmedi Hospital, Seoul, Republic of Korea.
Jaeku KangPriority Research Center, Myunggok Medical Research Institute, College of Medicine, Konyang University, Daejeon, Republic of Korea. jaeku@konyang.ac.kr.
Seok-Rae ParkPriority Research Center, Myunggok Medical Research Institute, College of Medicine, Konyang University, Daejeon, Republic of Korea. srpark@konyang.ac.kr.ORCID 0000-0002-1407-4495
Konyang University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Decidualization of the endometrial stromal cells (ESCs) is essential for successful embryo implantation. It involves the transformation of fibroblastic cells into epithelial-like cells that secrete cytokines, growth factors, and proteins necessary for implantation. Previous studies have revealed altered expression of miR-375 in the endometrium of patients with recurrent implantation failure and the ectopic stromal cells of patients with endometriosis. However, the exact molecular mechanisms, particularly the role of microRNAs (miRNAs) in the regulation of decidualization, remain elusive. In this study, we investigated whether decidualization is affected by miR-375 and its potential target(s). The findings demonstrated the downregulation of the expression of miR-375 in the secretory phase compared to its expression in the proliferative phase of the endometrium in normal donors. In contrast, it was upregulated in the secretory phase of the endometrium in infertility patients. Furthermore, during decidualization of ESCs in vitro, overexpression of miR-375 significantly reduced the transcript-level expression of forkhead box protein O1 (FOXO1), prolactin (PRL), and insulin-like growth factor binding protein-1 (IGFBP1), the well-known decidual cell markers. Overexpression of miR-375 also resulted in reduced decidualization-derived intracellular and mitochondrial reactive oxygen species (ROS) levels. Using the luciferase assay, we confirmed that NADPH oxidase 4 (NOX4) is a direct target of miR-375. Collectively, the study showed that the miR-375-mediated NOX4 downregulation reduced ROS production and attenuated the decidualization of ESCs. It provides evidence that miR-375 is a negative regulator of decidualization and could serve as a potential target for combating infertility.

Indexed as

InfertilityMicroRNAsCells, CulturedDeciduaEndometriumFemaleHumansNADPH Oxidase 4Reactive Oxygen SpeciesStromal CellsMicroRNAsMIRN375 microRNA, humanNADPH Oxidase 4NOX4 protein, humanReactive Oxygen SpeciesDecidualizationEndometrial stromal cellsmiR-375NOX4Reactive oxygen species

Identifiers

PMID35075615
PMCPMC9646565
OpenAlexW4210503393

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.